Contribution: Industrial Research Assistance Program – Contributions to Firms
Evolved Therapeutics Inc.
$547,500.00
Develop the EVO-ABGEN functional antibody discovery platform
EF 2023-24 · 2023-11-01
Résumé
The project will support the development of an antibody discovery platform. The platform facilitates the interrogation of full immune B-cell repertoires and accelerates identification of desired antibody candidates.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Vancouver|Vancouver, British Columbia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
725243406
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Additional Information
This agreement has been amended 2 time(s). The total amended value is 547,500 dollars.
Additional Information (French)
Cet accord a été modifié 2 fois La valeur totale des modifications est de 547 500 dollars.
Agreement End Date
2024-10-31
Agreement Number
1013608
Agreement Start Date
2023-11-01
Agreement Title
Develop the EVO-ABGEN functional antibody discovery platform
Agreement Title (French)
Développer la plateforme de découverte d’anticorps fonctionnels EVO-ABGEN
Agreement Type
Contribution
Agreement Value
$547,500.00
Amendment Date
2024-03-19
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The project will support the development of an antibody discovery platform. The platform facilitates the interrogation of full immune B-cell repertoires and accelerates identification of desired antibody candidates.
Description (French)
Le projet soutiendra le développement d’une plateforme de découverte d’anticorps. La plateforme facilite l’interrogation des répertoires complets de cellules B immunitaires et accélère l’identification des anticorps candidats souhaités.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Centre
Federal Riding (French)
Vancouver-Centre
Federal Riding Number
59034
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
725243406
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Evolved Therapeutics Inc.
Recipient Postal Code
V6E 4E5
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2023-2024-Q4-1013608
